Political rationale, aims, and outcomes of health-related high-level meetings and special sessions at the UN General Assembly: A policy research observational study.

IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL
PLoS Medicine Pub Date : 2022-01-13 eCollection Date: 2022-01-01 DOI:10.1371/journal.pmed.1003873
Paolo Rodi, Werner Obermeyer, Ariel Pablos-Mendez, Andrea Gori, Mario C Raviglione
{"title":"Political rationale, aims, and outcomes of health-related high-level meetings and special sessions at the UN General Assembly: A policy research observational study.","authors":"Paolo Rodi,&nbsp;Werner Obermeyer,&nbsp;Ariel Pablos-Mendez,&nbsp;Andrea Gori,&nbsp;Mario C Raviglione","doi":"10.1371/journal.pmed.1003873","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recognising the substantial political weight of the United Nations General Assembly (UNGA), a UN General Assembly special session (UNGASS) and high-level meetings (HLMs) have been pursued and held for 5 health-related topics thus far. They have focused on human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS, 2001), non-communicable diseases (NCDs, 2011), antimicrobial resistance (AMR, 2016), tuberculosis (TB, 2018), and universal health coverage (UHC, 2019). This observational study presents a comprehensive analysis of the political and policy background that prompted the events, as well as an assessment of aims, approaches, and ultimate outcomes.</p><p><strong>Methods and findings: </strong>We investigated relevant agencies' official documents, performed a literature search, and accessed international institutions' websites for the period 1990-2020. Knowledgeable diplomatic staff and experts provided additional information. Outcomes were evaluated from a United Nations perspective based on national and international commitments, and funding trends. Eliciting an effective governmental response through UNGASSs/HLMs is a challenge. However, increased international commitment was evident after the HIV/AIDS (2001), NCDs (2011), and AMR (2016) meetings. The more recent TB (2018) and UHC (2019) HLMs have received general endorsements internationally, although concrete commitments are not yet documented. Although attribution can only be hypothesized, financial investments for HIV/AIDS following the UNGASS were remarkable, whereas following HLMs for NCDs, AMR, and TB, the financial investments remained insufficient to face the burden of these threats. Thus far, the HIV/AIDS UNGASS was the only one followed by a level of commitment that has likely contributed to the reversal of the previous burden trend. Limitations of this study include its global perspective and aerial view that cannot discern the effects at the country level. Additionally, possible peculiarities that modified the response to the meetings were not looked at in detail. Finally, we assessed a small sample of events; thus, the list of strategic characteristics for success is not exhaustive.</p><p><strong>Conclusions: </strong>Overall, UNGASSs and HLMs have the potential to lay better foundations and boldly address key health challenges. However, to succeed, they need to (i) be backed by large consensus; (ii) engage UN authorities and high-level bodies; (iii) emphasise implications for international security and the world economy; (iv) be supported by the civil society, activists, and champions; and (v) produce a political declaration containing specific, measurable, achievable, relevant, and time-bound (SMART) targets. Therefore, to ensure impact on health challenges, in addition to working with the World Health Assembly and health ministries, engaging the higher political level represented by the UNGA and heads of state and government is critical.</p>","PeriodicalId":20368,"journal":{"name":"PLoS Medicine","volume":"19 1","pages":"e1003873"},"PeriodicalIF":10.5000,"publicationDate":"2022-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757909/pdf/","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLoS Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1371/journal.pmed.1003873","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 5

Abstract

Background: Recognising the substantial political weight of the United Nations General Assembly (UNGA), a UN General Assembly special session (UNGASS) and high-level meetings (HLMs) have been pursued and held for 5 health-related topics thus far. They have focused on human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS, 2001), non-communicable diseases (NCDs, 2011), antimicrobial resistance (AMR, 2016), tuberculosis (TB, 2018), and universal health coverage (UHC, 2019). This observational study presents a comprehensive analysis of the political and policy background that prompted the events, as well as an assessment of aims, approaches, and ultimate outcomes.

Methods and findings: We investigated relevant agencies' official documents, performed a literature search, and accessed international institutions' websites for the period 1990-2020. Knowledgeable diplomatic staff and experts provided additional information. Outcomes were evaluated from a United Nations perspective based on national and international commitments, and funding trends. Eliciting an effective governmental response through UNGASSs/HLMs is a challenge. However, increased international commitment was evident after the HIV/AIDS (2001), NCDs (2011), and AMR (2016) meetings. The more recent TB (2018) and UHC (2019) HLMs have received general endorsements internationally, although concrete commitments are not yet documented. Although attribution can only be hypothesized, financial investments for HIV/AIDS following the UNGASS were remarkable, whereas following HLMs for NCDs, AMR, and TB, the financial investments remained insufficient to face the burden of these threats. Thus far, the HIV/AIDS UNGASS was the only one followed by a level of commitment that has likely contributed to the reversal of the previous burden trend. Limitations of this study include its global perspective and aerial view that cannot discern the effects at the country level. Additionally, possible peculiarities that modified the response to the meetings were not looked at in detail. Finally, we assessed a small sample of events; thus, the list of strategic characteristics for success is not exhaustive.

Conclusions: Overall, UNGASSs and HLMs have the potential to lay better foundations and boldly address key health challenges. However, to succeed, they need to (i) be backed by large consensus; (ii) engage UN authorities and high-level bodies; (iii) emphasise implications for international security and the world economy; (iv) be supported by the civil society, activists, and champions; and (v) produce a political declaration containing specific, measurable, achievable, relevant, and time-bound (SMART) targets. Therefore, to ensure impact on health challenges, in addition to working with the World Health Assembly and health ministries, engaging the higher political level represented by the UNGA and heads of state and government is critical.

Abstract Image

Abstract Image

Abstract Image

联合国大会卫生相关高级别会议和特别会议的政治理由、目标和结果:一项政策研究观察性研究
背景:认识到联合国大会(UNGA)的重大政治影响力,迄今已就5个卫生相关主题举行了联合国大会特别会议(UNGASS)和高级别会议(HLMs)。它们的重点是人类免疫缺陷病毒/获得性免疫缺陷综合征(艾滋病毒/艾滋病,2001年)、非传染性疾病(NCDs, 2011年)、抗微生物药物耐药性(AMR, 2016年)、结核病(TB, 2018年)和全民健康覆盖(UHC, 2019年)。这项观察性研究全面分析了引发这些事件的政治和政策背景,并对目标、方法和最终结果进行了评估。方法与发现:通过查阅1990-2020年相关机构的官方文件,进行文献检索,并访问国际机构网站。知识渊博的外交人员和专家提供了更多的资料。根据国家和国际承诺以及供资趋势,从联合国的角度对成果进行了评估。通过ungass /高级别管理机制促使政府作出有效反应是一项挑战。然而,在艾滋病毒/艾滋病(2001年)、非传染性疾病(2011年)和抗菌素耐药性(2016年)会议之后,国际社会的承诺明显增加。最近的结核病(2018年)和全民健康覆盖(2019年)高级别管理文件已在国际上得到普遍认可,但尚未记录具体承诺。虽然归因只能假设,但特别会议之后对艾滋病毒/艾滋病的财政投资是显著的,而在非传染性疾病、抗生素耐药性和结核病的高级别会议之后,财政投资仍然不足以应对这些威胁的负担。迄今为止,艾滋病毒/艾滋病特别会议是唯一一次作出了一定程度的承诺,可能有助于扭转以前的负担趋势。本研究的局限性包括其全球视角和鸟瞰图,无法辨别国家一级的影响。此外,没有详细研究可能改变对会议反应的特殊情况。最后,我们评估了一小部分事件样本;因此,成功的战略特征清单并不详尽。结论:总体而言,unasss和HLMs有潜力奠定更好的基础,并大胆应对关键的卫生挑战。然而,要取得成功,它们需要:(1)得到广泛共识的支持;(ii)与联合国当局和高级别机构接触;强调对国际安全和世界经济的影响;(四)得到民间社会、活动家和倡导者的支持;(v)提出一份政治宣言,其中包含具体的、可衡量的、可实现的、相关的和有时限的(SMART)目标。因此,为了确保对卫生挑战产生影响,除了与世界卫生大会和各国卫生部合作外,以大会以及国家元首和政府首脑为代表的更高政治层面的参与至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
PLoS Medicine
PLoS Medicine 医学-医学:内科
CiteScore
21.60
自引率
0.60%
发文量
227
审稿时长
3 months
期刊介绍: PLOS Medicine aims to be a leading platform for research and analysis on the global health challenges faced by humanity. The journal covers a wide range of topics, including biomedicine, the environment, society, and politics, that affect the well-being of individuals worldwide. It particularly highlights studies that contribute to clinical practice, health policy, or our understanding of disease mechanisms, with the ultimate goal of improving health outcomes in diverse settings. Unwavering in its commitment to ethical standards, PLOS Medicine ensures integrity in medical publishing. This includes actively managing and transparently disclosing any conflicts of interest during the reporting, peer review, and publication processes. The journal promotes transparency by providing visibility into the review and publication procedures. It also encourages data sharing and the reuse of published work. Author rights are upheld, allowing them to retain copyright. Furthermore, PLOS Medicine strongly supports Open Access publishing, making research articles freely available to all without restrictions, facilitating widespread dissemination of knowledge. The journal does not endorse drug or medical device advertising and refrains from exclusive sales of reprints to avoid conflicts of interest.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信